31R and RVV Related Headlines

Go Back

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

31R and RVV Related Press Releases

Go Back

Nov 21, 2025 12:07PM Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

31R and RVV Related SEC Filings

Go Back